Prospective randomised clinical trial testing the role of prophylactic cranial radiotherapy in patients treated with Trastuzumab (Herceptin) for metastatic breast cancer.

Trial Profile

Prospective randomised clinical trial testing the role of prophylactic cranial radiotherapy in patients treated with Trastuzumab (Herceptin) for metastatic breast cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2015

At a glance

  • Drugs Trastuzumab (Primary) ; Taxanes
  • Indications Advanced breast cancer; Brain metastases
  • Focus Therapeutic Use
  • Acronyms HER-PCI
  • Most Recent Events

    • 06 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 31 May 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
    • 17 Jan 2011 Planned End Date changed from 30 Oct 2010 to 30 Apr 2010 as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top